HSD11B1
11-beta-hydroxysteroid dehydrogenase 1
Also known as: DHI1_HUMAN, HSD11, HSD11B, SDR26C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28845
- Gene
- HSD11B1
- Ensembl
- ENSG00000117594
- Chromosome
- 1
- Canonical length
- 292 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a microsomal enzyme that catalyzes the conversion of the stress hormone cortisol to the inactive metabolite cortisone. In addition, the encoded protein can catalyze the reverse reaction, the conversion of cortisone to cortisol. Too much cortisol can lead to central obesity, and a particular variation in this gene has been associated with obesity and insulin resistance in children. Mutations in this gene and H6PD (hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)) are the cause of cortisone reductase deficiency. Alternate splicing results in multiple transcript variants encoding the same protein.[provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
292 residues, UniProt reviewed canonical sequence.
>P28845|HSD11B1
1 MAFMKKYLLP ILGLFMAYYY YSANEEFRPE MLQGKKVIVT GASKGIGREM AYHLAKMGAH
61 VVVTARSKET LQKVVSHCLE LGAASAHYIA GTMEDMTFAE QFVAQAGKLM GGLDMLILNH
121 ITNTSLNLFH DDIHHVRKSM EVNFLSYVVL TVAALPMLKQ SNGSIVVVSS LAGKVAYPMV
181 AAYSASKFAL DGFFSSIRKE YSVSRVNVSI TLCVLGLIDT ETAMKAVSGI VHMQAAPKEE
241 CALEIIKGGA LRQEEVYYDS SLWTTLLIRN PCRKILEFLY STSYNMDRFI NKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSD11B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 905 nTPM
Expression across tissuesHPA
Tissue
- liver: 905 nTPM
- placenta: 68 nTPM
- ovary: 56 nTPM
- lung: 39 nTPM
- skin: 33 nTPM
- prostate: 28 nTPM
Single-cell type
- hepatocytes: 893 nCPM
- endometrial luminal cells: 325 nCPM
- epididymal basal cells: 123 nCPM
- endometrial secretory cells: 95 nCPM
- fibroblasts: 68 nCPM
- endometrial glandular cells: 59 nCPM
Immune cell
- memory CD4 T-cell: 5.7 nTPM
- T-reg: 1.7 nTPM
- memory CD8 T-cell: 1.2 nTPM
- MAIT T-cell: 0.4 nTPM
- total PBMC: 0.4 nTPM
- NK-cell: 0.3 nTPM
Brain region
- cerebellum: 35 nTPM
- midbrain: 31 nTPM
- white matter: 23 nTPM
- pons: 21 nTPM
- cerebral cortex: 20 nTPM
- hypothalamus: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HSD11B1.
Disease | AllUniProt
Conditions HSD11B1 is implicated in, by any mechanism.
- Cortisone reductase deficiency 2 (CORTRD2) MIM:614662
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 33 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cortisone reductase deficiency 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cortisol dehydrogenase (NADP+) activity
- NADP binding
- protein homodimerization activity
- steroid binding
- 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
- 7-beta-hydroxysteroid dehydrogenase (NADP+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSD11B1 as an antibody target. Whether an autoantibody or antibody against HSD11B1 could matter depends on whether native HSD11B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSD11B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HSD11B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...